Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THC for anorexia in advanced cancer with chemosensory abnormalities
NCT00316563Phase 2Completed
- Sponsor
- Alberta Health Services
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dronabinol in cancer-induced anorexia, sponsored by Alberta Health Services. Started Aug 2006; status: completed.
02
Drugs
dronabinol
03
Conditions
cancer-induced anorexia
Beyond the preview
Go deeper on NCT00316563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00316563.